Boston Scientific (BSX) Deferred Taxes (2020 - 2026)

Boston Scientific has disclosed Deferred Taxes across 7 years of filings, most recently posting -$351.0 million for Q1 2026.

• Deferred Taxes for Q1 2026 came in at -$351.0 million, down 956.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$404.0 million (down 573.33% YoY), and the FY2025 annual result was -$12.0 million, up 82.86% from the prior year.
• Deferred Taxes came in at -$351.0 million for Q1 2026 at Boston Scientific, down from -$32.0 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $73.0 million in Q4 2023 to a low of -$351.0 million in Q1 2026.
• The 5-year median for Deferred Taxes is -$11.0 million (2024), against an average of -$29.2 million.
• Across the five-year window, Deferred Taxes sank 7400.0% in 2022 and surged 942.86% in 2023, its largest moves.
• Boston Scientific's Deferred Taxes stood at $7.0 million in 2022, then soared by 942.86% to $73.0 million in 2023, then tumbled by 209.59% to -$80.0 million in 2024, then jumped by 60.0% to -$32.0 million in 2025, then plunged by 996.88% to -$351.0 million in 2026.
• The last three Deferred Taxes figures came in at -$351.0 million (Q1 2026), -$32.0 million (Q4 2025), and $69.0 million (Q3 2025), per Business Quant data.